7 results match your criteria: "University of Connecticut School of Pharmacy. Storrs[Affiliation]"
J Am Coll Emerg Physicians Open
December 2024
Department of Emergency Medicine University of Cincinnati Cincinnati Ohio USA.
Objectives: This study describes clinical characteristics and management strategies for patients with factor Xa (FXa) inhibitor-related traumatic non-intracranial bleeds who were treated with andexanet alfa or four-factor prothrombin complex concentrate (4F-PCC).
Methods: An observational cohort study (ClinicalTrials.gov Identifier: NCT05548777) was conducted using electronic health records from 354 US hospitals.
Rev Gastroenterol Peru
July 2024
Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola. Lima, Peru; Health Outcomes, Policy and Evidence synthesis (HOPES) Group, University of Connecticut School of Pharmacy. Storrs, CT, USA.
J Am Coll Emerg Physicians Open
June 2023
Department of Pharmacy Practice University of Connecticut School of Pharmacy Storrs Connecticut USA.
Objective: To characterize the burden of illness associated with oral factor Xa (FXa) inhibitor-related bleeding in the US Medicare population.
Methods: This retrospective cohort study used the full 20% Medicare random sample claims database to identify patients who experienced their first hospitalization for an FXa inhibitor-related major bleed between October 2013 and September 2017. Bleeding types were classified as intracranial hemorrhage (ICH), gastrointestinal (GI), and other.
Antimicrob Steward Healthc Epidemiol
December 2021
University of Connecticut School of Pharmacy Storrs, Connecticut.
Background There is a paucity of contemporary data estimating the incidence of major adverse cardiovascular events (MACE) in patients with established atherosclerotic disease or multiple risk factors managed in routine practice. We estimated 1- and 4-year incidences of MACE and the association between MACE and vascular beds affected in these patients. Methods and Results Using US IBM MarketScan data from January 1, 2013 to December 31, 2017, we identified patients ≥45 years old with established coronary artery disease, cerebrovascular disease, peripheral artery disease, or the presence of ≥3 risk factors for atherosclerosis during 2013 with a minimum of 4 years of follow-up.
View Article and Find Full Text PDFPharm Pract (Granada)
April 2011
Office of Assessment and Accreditation, University of Connecticut School of Pharmacy. Storrs, CT ( United States ).
Objective: The goal of this study was to assess for a predominance of learning styles among pharmacy students at an accredited U.S. school of pharmacy.
View Article and Find Full Text PDF